Maintenance Therapy With Sunitinib or Observation in Metastatic Pancreatic Cancer: a Phase II Randomized Trial.

Trial Profile

Maintenance Therapy With Sunitinib or Observation in Metastatic Pancreatic Cancer: a Phase II Randomized Trial.

Completed
Phase of Trial: Phase II

Latest Information Update: 30 Nov 2013

At a glance

  • Drugs Sunitinib (Primary)
  • Indications Pancreatic cancer
  • Focus Biomarker; Pharmacogenomic; Therapeutic Use
  • Acronyms PACT-12
  • Most Recent Events

    • 02 Oct 2012 Pharmacogenomic results presented at the 37th Congress of the European Society of Medical Oncology.
    • 05 Jun 2012 Clinical and translational results presented at the 48th Annual Meeting of the American Society of Clinical Oncology.
    • 31 Jan 2012 Actual patient number 56 added as reported by ClinicalTrials.gov.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top